Navigation Links
Resverlogix Presenting at Biotech Showcase
Date:1/11/2010

TSX Exchange Symbol: RVX

Also participating at 28th Annual JP Morgan Healthcare conference

SAN FRANCISCO, CA and CALGARY, Jan. 11 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that Donald J. McCaffrey will be presenting at the Biotech Showcase 2010 conference on Tuesday, January 12, 2009 at the Marines' Memorial Club and Hotel in San Francisco, California.

Biotech Showcase provides presenting companies an opportunity to present to an audience of investors and biopharmaceutical executives during the course of the industry's largest annual healthcare investor conference. In conjunction with this presentation Resverlogix will also be participating in the annual JP Morgan Healthcare conference, which is a separate event that is taking place at the Sir Francis Drake Hotel also in San Francisco.

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet medical needs. The NexVas(TM) PR program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the burden of atherosclerosis and other important diseases such as Acute Coronary Syndrome, Diabetes, Alzheimer's disease, Peripheral Artery Disease and other vascular disorders. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit www.resverlogix.com.

This news release may contain certain forward-looking statements as defined under applicable Canadian securities legislation, including our vision to be a leader in the re
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Resverlogix Commences Phase 2 Atherosclerosis Clinical Trial
2. Resverlogix Updates Shareholders on Accelerated Clinical Trial Plan
3. Resverlogix Appoints A. Brad Cann as Chief Financial Officer
4. Resverlogix RVX-208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers
5. Resverlogix Phase 1b/2a Study Meets Primary Endpoint
6. Resverlogixs Success in Inflammation Program Results in 2 Patents Filed
7. Resverlogix Provides Quarterly Update
8. Resverlogix Board of Directors Update
9. Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
10. Resverlogix Announces Closing of Debt Redemption
11. Resverlogix Eliminates Sixty Percent of Remaining Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... GUELPH, ON , April 16, 2015 /CNW/ - Bioenterprise ... opening its newest office in Charlottetown ... with the Prince Edward Island ADAPT Council for the ... are looking forward to working with PEI ADAPT.  They ... Maritimes for more than a decade," explains Dave ...
(Date:4/16/2015)... SAN DIEGO , April 16, 2015 /PRNewswire/ ... and development of therapeutic antibodies, today announced ... (IL-36R) antibody program into IND-enabling studies. The ... a novel treatment for generalized pustular psoriasis ... high unmet medical need. ANB019 is wholly owned ...
(Date:4/16/2015)... ROCKLAND, Mass. , April 16, 2015 /PRNewswire/ ... of Merck KGaA, Darmstadt, Germany ... Senior Vice President, Head of Global Clinical Development. ... development expertise, including experience in Oncology and Immunology. ... leadership ability, having served as a Vice President ...
(Date:4/16/2015)... April 16, 2015 Fairleigh Dickinson ... V. Gulfo to become the Executive Director of ... FDU announced the kick-off of the Initiative for ... by Dr. Gulfo, under the Rothman Institute of ... Business) and in collaboration with FDU’s School of ...
Breaking Biology Technology:Bioenterprise Corporation Expands into the Maritimes 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 2Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... - Sonic Foundry, Inc. , has announced ... million shares of common stock at $3.75 per share. ... to close on Dec. 27, 2006, will be used ... to the company's search technology and intellectual property protection. ...
... the University of Wisconsin-Madison , justified or otherwise, ... to the tree. It has world-class scientists and well-developed ... services, but most of that commercialization takes place within ... that's true. Just check the figures for per capita ...
... the theory that consumer need is what drives business formation, ... , ,In this case, the need is created when ... be desired, and the chief executive of a new business ... problems before. , ,Albert Chiozzi, who plans to launch ...
Cached Biology Technology:Entrepreneurship grant will build strong foundation 2Entrepreneurship grant will build strong foundation 3Entrepreneurship grant will build strong foundation 4Company to operate in wireless Internet space 2
(Date:3/23/2015)... March 23, 2015 SoundView Technology Group issues a ... NXTD ) Wocket smart wallet. SoundView was one of the ... their experience with the Wocket in multiple scenarios and outlets. ... Foods and other retailers, making both debit and credit card ... also says, "If the company meets their plans in 2015, ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Hand Geometry - Global Strategic Business Report" report to ... for Hand Geometry in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and ...
(Date:3/17/2015)... , March 17, 2015 MedNet ... specializing in clinical study management systems, is pleased ... attendance at ARENA,s Outsourcing in Clinical Trials Southeast ... event provides an excellent forum for MedNet to ... and affordable software-as-a-service (SaaS) eClinical technology platform. ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... The American Association for the Advancement of Science (AAAS) ... the Department of Entomology at the University of Illinois ... Understanding of Science and Technology Award. Berenbaum was ... research on the world of insects with her inspirational ...
... identified the specific region in vertebrates where adult blood stem ... in a paper in this week,s early online edition of ... for the development of safer and more effective stem cell ... host of other diseases of the blood or bone marrow. ...
... set of proteins found in our intestines can recognize and ... surfaces, scientists at Emory University School of Medicine have discovered. ... scheduled to appear in the journal Nature Medicine . ... on the surfaces of bacteria, but these proteins are different ...
Cached Biology News:Entomologist May R. Berenbaum wins Public Understanding of Science Award 2Entomologist May R. Berenbaum wins Public Understanding of Science Award 3Biologists image birth of blood-forming stem cells in embryo 2Biologists image birth of blood-forming stem cells in embryo 3Bacteria-killing proteins cover blood type blind spot 2Bacteria-killing proteins cover blood type blind spot 3
... SureLINK Bioconjugation Kit provides a powerful ... carbohydrates and nuceleic acids. The kit provides ... with reagents for quantifying conjugation efficiencies. It ... fluorophores, biotin and other tags with a ...
... offers maleimide activated carrier proteins to ... Imject Maleimide Activated Carrier Proteins are ... preactivated with a heterobifunctional cross-linker (Sulfo-SMCC). ... sulfhydryl-reactive carrier protein. Thus allowing ...
...
... perfect complement to high-speed analytical techniques, the AutoTrace SPE is a powerful, high-throughput ... cartridge conditioning, sample loading and elution steps for large volumes aqueous solution extractions ... ... ...
Biology Products: